How to manage multi-jurisdictional IP portfolios in the Asia Pacific Rim, in view of the Intellectual Property Provisions of the TPP, the ASEAN Framework Agreement on IP Cooperation and the Memorandum of Understanding between ASEAN Countries and China in respect
The intellectual property provisions are a source of controversy, especially in terms of their effects on pharmaceutical patents and digital innovation. TPP and Asean members, as well as China, agree that they will follow and expand upon the legal rights and obligations delineated in the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), and the agreement's discussions thus far have included trademark, geographical indication, copyright and related rights, patents, trade secrets, genetic resources, and traditional. This session will include a hypothetical case scenario and strategic discussion among the panelists regarding where to file, how to gain leverage and what other considerations arise in different jurisdictions.
- Michael Soo, Shook Lin & Bok
- Ayumu Iijima, Innoventier
- Daniel Lim, Joyce A. Tan & Partners LLC
- Bo Kyung Lim, Shin & Kim
- Lidong Pan, Co-effort Reiz
- Thomas Suh, LTL Attorneys LLP